Michael Geffner
Chief Tech/Sci/R&D Officer at IMMUNOVANT, INC.
Net worth: 4 M $ as of 2024-06-29
Profile
Michael Geffner is currently the Chief Medical Officer at Immunovant, Inc. He previously worked as a Principal at Merck & Co., Inc. and as the Head-Global Medical Affairs at Achillion Pharmaceuticals, Inc. from 2015 to 2020.
From 2020 to 2022, he served as the Chief Medical Officer & Head-Product Development at BlueSphere Bio, Inc. He also worked as a Principal at Clindevex Consulting, Inc. Dr. Geffner holds an MBA from Fairleigh Dickinson University and a doctorate from Albany Medical College.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
IMMUNOVANT INC
0.10% | 2024-04-23 | 141,616 ( 0.10% ) | 4 M $ | 2024-06-29 |
Michael Geffner active positions
| Companies | Position | Start |
|---|---|---|
| IMMUNOVANT, INC. | Chief Tech/Sci/R&D Officer | - |
Former positions of Michael Geffner
| Companies | Position | End |
|---|---|---|
BlueSphere Bio, Inc.
 BlueSphere Bio, Inc. Pharmaceuticals: MajorHealth Technology BlueSphere Bio, Inc. manufactures oncology drugs products. The company was founded by Mark Shlomchik, Warren Shlomchik, and Constantinos Panousis and is headquartered in Pittsburgh, PA. | Chief Tech/Sci/R&D Officer | 2022-05-31 |
| ACHILLION PHARMACEUTICALS, INC. | Corporate Officer/Principal | 2020-03-31 |
| MERCK & CO., INC. | Corporate Officer/Principal | - |
Training of Michael Geffner
| Albany Medical College | Doctorate Degree |
| Fairleigh Dickinson University | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| IMMUNOVANT, INC. | Health Technology |
| MERCK & CO., INC. | Health Technology |
| Private companies | 2 |
|---|---|
Achillion Pharmaceuticals, Inc.
 Achillion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Achillion Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of oral small molecule complement system inhibitors. Its pipeline includes Danicopan and ACH-5228. The company was founded on August 17, 1998 and is headquartered in Blue Bell, PA. | Health Technology |
BlueSphere Bio, Inc.
BlueSphere Bio, Inc. Pharmaceuticals: MajorHealth Technology BlueSphere Bio, Inc. manufactures oncology drugs products. The company was founded by Mark Shlomchik, Warren Shlomchik, and Constantinos Panousis and is headquartered in Pittsburgh, PA. | Health Technology |
- Stock Market
- Insiders
- Michael Geffner
